MPLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
MapLight Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$8.00+0.30 (+3.90%)
Close on Oct 19, 2026
- Market cap
- $363.45M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$8.92 (−52.72%)since Oct 31, 2025
Weekly closes, adjusted for splits, on a log scale. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $363.45M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.04
- Dividend yield
- –
- Free cash flow yield
- -48.18%
Fundamentals
- Net income
- -$229.83M
- EPS, diluted
- -$18.56
- Free cash flow
- -$175.12M
- Book value per share
- $7.67
- Diluted shares
- 45M
Three years at a glance
Fiscal years 2023 to 2025 and trailing twelve months, USD
Operating income
-$242.93M
Net income
-$229.83M
EPS, diluted
–
Free cash flow
-$175.12M
Reported periodTrailing twelve months